miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44

Lina Sun(Hebei Medical University), Xin Wang(Jiangsu University)

Theranostics

January 1, 2019

10.7150/thno.36605

Cited by 86

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome

|Science|2002|370

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing

|Journal of Translational Medicine|2021|91

LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation

|Nature Communications|2023|67

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer

|BMC Medicine|2022|64